Table 2 Association between perioperative scopolamine administration and postoperative mortality
Cohort | Patients in Cohort (after matching) | Deceased patients | Risk (%) | Relative Risk | Confidence Interval (95%) | P value |
|---|---|---|---|---|---|---|
Surgery & Scopolamine 70+ | 59,050 | 4,147 | 7.023% | 4.126 | (3.855 to 4.417) | < 0.0001 |
Surgery & No Scopolamine 70+ | 59,050 | 1,005 | 1.702% | Â | Â | Â |
Surgery & Scopolamine 60–69 | 44,193 | 719 | 1.627% | 3.034 | (2.621 to 3.511) | < 0.0001 |
Surgery & No Scopolamine 60–69 | 44,193 | 237 | 0.536% |  |  |  |
Surgery & Scopolamine 50–59 | 35,830 | 240 | 0.67% | 2.424 | (1.919 to 3.062) | < 0.0001 |
Surgery & No Scopolamine 50–59 | 35,830 | 99 | 0.276% |  |  |  |
Surgery & Scopolamine 40–49 | 29,295 | 103 | 0.352% | 2.512 | (1.75 to 3.606) | < 0.0001 |
Surgery & No Scopolamine 40–49 | 29,295 | 41 | 0.14% |  |  |  |
Surgery & Scopolamine 30–39 | 22,085 | 70 | 0.317% | 2.414 | (1.566 to 3.72) | < 0.0001 |
Surgery & No Scopolamine 30–39 | 22,085 | 29 | 0.131% |  |  |  |
Surgery & Scopolamine 20–29 | 11,455 | 25 | 0.218% | 1.923 | (0.984 to 3.757) | 0.0514 |
Surgery & No Scopolamine 20–29 | 11,455 | 13 | 0.113% |  |  |  |